Senator questions FDA, Synthes on possible conflicts of interest

02/27/2008 | NYTimes.com

The FDA and Synthes, maker of the Prodisc artificial spinal disc, received letters of inquiry from Sen. Charles E. Grassley, R-Iowa, regarding possible conflicts of interest among doctors connected to the clinical trials of the device. A Synthes spokesman said the company will cooperate in the inquiry, while an FDA spokeswoman said the agency does not comment on pending requests.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL